Like Ignite Health

closed 3/1/2007 via

inVentiv Health, Inc., acquired Ignite Health

synopsis: inVentiv Health, Inc. has signed a definitive agreement to acquire Ignite Health, an independent healthcare advertising agency that uses a technology-centric approach to communicate with people living with chronic diseases and those who care for them.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Ignite Health
Ignite Health is a new breed of advertising agency with a fresh approach to healthcare marketing and communications. By complementing highly focused print strategies with a wide range of tailored electronic strategies the company helps clients meet their objectives effectively and efficiently.
price ($mm)
$20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/11/2007 via BusinessWire

Publicis Groupe SA, acquired Multimedia Healthcare Communication S.r.l.

synopsis: Publicis Groupe has acquired Multimedia Healthcare Communications S.r.l., a move designed to reinforce its offer in digital and healthcare communication services in Italy. Multimedia Healthcare Communication S.r.l. (Milan), leading independent market development and public relations agency.
buyer: Publicis Groupe SA (ENXTPA:PUB:$10,107.60)
Publicis Groupe is the world's fourth largest communications group, as well as world's second largest media counsel and buying group. Groupe's communication activities cover advertising, through three autonomous global advertising networks: Leo Burnett, Publicis, and Saatchi & Saatchi. "
target: Multimedia Healthcare Communication S.r.l.
Multimedia Healthcare Communications S.r.l. Multimedia is a PR and advertising planning agency with a structure of 15 healthcare-devoted professionals. The agency offers services to pharmaceutical companies and other institutions, and is specialized in PR, Media Relations and education campaigns.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/16/2011 via PR Newswire

MDC Partners, Inc., acquired Concentric Pharma Advertising

synopsis: MDC Partners has acquired a majority stake in leading healthcare and pharma advertising and marketing agency, Concentric Pharma Advertising. Named 2011 Agency of the Year by the Med Ad News, Concentric is a full-service, independent, healthcare advertising and promotion agency with a focus on the specialty pharma sector.
buyer: MDC Partners, Inc. (MDCA:$1,427.49)
MDC Partners utilizes technology, marketing communications, data analytics, insights and strategic consulting solutions to drive meaningful returns on Marketing and Communications Investments for multinational clients in the United States, Canada, Europe, and the Caribbean. "
target: Concentric Pharma Advertising
Concentric Pharma Advertising is a full-service, independent, healthcare advertising and promotion agency with a focus on the specialty pharma sector. Concentric has built a top tier client list that includes Alcon Labs, Allergan, Bayer HealthCare, Discovery Labs, Genentech, and many more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/12/2011 via PR Newswire

Publicis Healthcare Communications, acquired Dreams Communication

synopsis: Publicis Groupe announced that it has acquired Dreams Communication, a Chinese agency specialized in healthcare communications regrouping Beijing Dreams Advertising and Beijing Dreams Zhiyang Communication. Dreams will become part of Publicis Healthcare Communications Group and will be renamed Publicis Life Brands Dreams.
buyer parent: Publicis Groupe SA
buyer: Publicis Healthcare Communications
Publicis Healthcare Communications Group is the largest health-oriented agency network in the world. It manages top-tier agencies specializing in promoting innovative solutions in advertising, medical education, sales and marketing, digital, market access, and medical and scientific affairs. "
target: Dreams Communication
Dreams Communication is a Chinese agency specialized in healthcare communications regrouping Beijing Dreams Advertising and Beijing Dreams Zhiyang Communication. It offers advertising and design, digital, medical education, and event planning services to mainly pharmaceutical and healthcare clients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/13/2010 via PR Newswire

Rosetta Marketing Group, LLC, acquired Wishbone Advertising

synopsis: Rosetta, the nation's largest independent interactive marketing agency, and Wishbone, the award-winning professional healthcare marketing agency, announced the acquisition of Wishbone by Rosetta.
buyer parent: Lindsay Goldberg & Bessemer
buyer: Rosetta Marketing Group, LLC
Rosetta helps clients translate deep consumer insights into Personalized Marketing programs on the web, in call centers, direct mail, and face-to-face selling, in order to drive significant improvements in clients' ROI. "
target: Wishbone Advertising
Founded in 1998, Wishbone is a full-service pharmaceutical advertising agency that was awarded "Agency of the Year" honors in 2009. Since its inception, Wishbone has defined its mission as delivering "the big-agency experience without the big-agency bureaucracy."
price ($mm)
rev ($mm)
$15
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 8/18/2009 via Market Wire

Cascadia Investments, Inc., acquired PharmADS.com

synopsis: Cascadia Investments, Inc announces the acquisition of www.pharmads.com, a boutique advertising network specifically designed for use by advertisers and publishers of pharmaceutical-related brands, sites, and products.
buyer: Cascadia Investments, Inc. (CDIV:$0.00)
Cascadia Investments, Inc. is a publicly traded, real estate development company operating in the Pacific Northwest. "
target: PharmADS.com
PharmAds is a boutique ad network specifically designed for use by advertisers and publishers with pharmaceutical related brands, sites, or products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/8/2009 via PR Newswire

Health Club Media Network, acquired Alloy Fitness Network

synopsis: Health Club Media Network (HCMN), the nation's largest provider of advertising and marketing opportunities for national brands in health clubs, announced its acquisition of the Alloy Fitness Network from Alloy Media + Marketing.
buyer: Health Club Media Network
Founded in 1995, HCMN (formerly the Health Club Panel Network) has grown to become the largest and most reputable player in the field of health club advertising and marketing. HCMN's exclusive network now extends to nearly 4,000 clubs across 49 states and 120+ DMAs. "
target parent: Alloy Media + Marketing
target: Alloy Fitness Network
Alloy Fitness Network is a leading health club advertising network with over 3000 physical media placements in over 700 health clubs across the US.
price ($mm)
$0.14
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2008 via PR Newswire

HealthCare.com, Inc., acquired BrokersWeb.com

synopsis: HealthCare.com, Inc. announced the acquisition of BrokersWeb, a leading provider of targeted, performance-based online advertising to health insurance brokers and lead aggregators. In addition to operating the BrokersWeb health insurance pay-per-click (PPC) platform, BrokersWeb also owns and operates HealthInsuranceFinders.com.
buyer: HealthCare.com, Inc.
HealthCare.com, with its flagship web property at http://www.healthcare.com, features Care Provider Search(TM), the web's leading healthcare provider directory connecting health consumers with health care professionals and health care-related businesses. "
target: BrokersWeb.com
Brokers Web is a division of Allhealth Insurance Services, Inc., best known for their highly visible and popular website, www.healthinsurancefinders.com.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/8/2010 via GlobeNewswire

inVentiv Health, Inc., acquired Star Terre Santé

synopsis: inVentiv Health, a provider of end-to-end clinical development, launch and commercialization services to the healthcare industry, announced that it has acquired Substrat'Homme SA, commonly known as Star Terre Santé. Star Terre Santé will provide advertising and promotional services to inVentiv Communications' clients in France and Benelux.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is a leading, global provider of data-driven, outsourced solutions to the pharmaceutical, life sciences and healthcare industries. inVentiv's full suite of marketing, sales, clinical development and post-approval solutions drive speed and effectiveness. "
target: Star Terre Santé
Substrat'Homme SA, commonly known as Star Terre Santé, is a leading group of healthcare marketing and communications agencies based in Paris.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/23/2008 via BusinessWire

Publicis Healthcare Communications Group, acquired Reed Weir Communications

synopsis: Publicis Healthcare Communications Group, part of Publicis Groupe, announced that it has acquired Sydney-based Reed Weir Communications, one of Australia’s most competitive independent healthcare communications agencies.
buyer parent: Publicis Groupe SA
buyer: Publicis Healthcare Communications Group
Publicis Healthcare Communications Group is one of the largest healthcare communications groups in the world. Worldwide healthcare services include advertising, medical education, sales, marketing, and digital, as well as medical and scientific affairs. "
target: Reed Weir Communications
Reed Weir Communications develops strategies in marketing communications, crisis management and media relations. The agency’s clients include some of the most celebrated brands of the human and animal health industries such as Bayer, GSK, CSL, Eli Lilly, McKesson and Hill’s Pet Nutrition.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/3/2007 via PR Newswire

Diversified Agency Services, acquired Consultech

synopsis: Omnicom Group Inc., the leading global advertising and marketing services group, has acquired, through its Diversified Agency Services division, a majority ownership interest in Consultech, a leading healthcare market consulting and marketing communications company based in China.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS): a global enterprise of more than 100 companies that provide services in direct marketing/consulting, public relations, promotional marketing, and specialty communications. "
target: Consultech
Consultech is one of the leading Healthcare Consulting and Marketing Communications companies in China. It enables its clients to grow by integrating local insights with international practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/10/2007 via PR Newswire

Monitor Clipper Partners Inc., acquired Access Communications, LLC

synopsis: Access Communications, LLC, a premier strategic health care marketing and communications agency, has recapitalized its ownership structure by partnering with Monitor Clipper Partners, a private equity firm based in Cambridge, Mass. The partnership will provide Access with greater resources to achieve its long-term growth objectives.
buyer parent: The Monitor Group
buyer: Monitor Clipper Partners Inc.
Monitor Clipper Partners is a private equity firm investing in middle market management buyouts, recapitalizations and growth equity financings. MCP partners with strong management teams that can benefit from MCP's privileged relationship with Monitor Group. "
target: Access Communications, LLC
Access Communications, LLC, is a leading health care marketing agency. The company offers pharmaceutical, biopharmaceutical and specialty medical clients a vast portfolio of integrated payer, purchaser, prescriber, and patient programs, as well as promotional and medical education services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/24/2005 via PR Newswire

WhittmanHart, acquired Insight Interactive Group, Inc.

synopsis: WHITTMANHART, INC. announced today that it has acquired Insight Interactive Group, Inc., a full service interactive communications firm specializing in the healthcare and pharmaceutical vertical markets.
buyer: WhittmanHart
WhittmanHart Interactive is an ideas-driven agency that creates cutting edge, user-friendly digital solutions for our clients. We're a fast-growing company with offices throughout the US, serving some of the most well-known brands in the world. "
target: Insight Interactive Group, Inc.
Insight Interactive Group offers a comprehensive range of services to promote brand recognition and loyalty, resulting in increased prescriptions and patient compliance. Founded in 1999 with eight employees, Insight Interactive today employs more than 40. Insight Interactive Group's deep healthcare
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/19/2011 via BusinessWire

Quintiles Transnational Corp., acquired VCG

synopsis: Quintiles announced the acquisition of VCG & Associates and VCG BIO ("VCG"), based in Holliston, Mass., and Cave Creek, Ariz., respectively. The addition of VCG strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. "
target: VCG
VCG develops strategic healthcare marketing initiatives to address the challenges surrounding U.S. pharmaceutical market entry. It focuses on biopharma companies that need supplemental resources to maximize commercial opportunities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/13/2011 via PR Newswire

MD On-Line, Inc., acquired Strategic EDGE Communications, Inc.

synopsis: MD On-Line, a proven leader in providing innovative technology solutions that power providers' ability to address tomorrow's practice and patient needs, announced that it has acquired Strategic EDGE Communications, Inc., a global healthcare communications partner to pharmaceutical, biotechnology and medical device companies.
buyer: MD On-Line, Inc.
MD On-Line Inc. is a leading provider of electronic data interchange (EDI) solutions that facilitate the critical connection between doctors and payers. Its offerings enable electronic data capture and entry, and claim and transactional data submission to payers. "
target: Strategic EDGE Communications, Inc.
Strategic EDGE Communications, Inc., is a comprehensive marketing services organization that operates globally to provide a suite of services, including: advertising and promotion, brand identity and development, interactive marketing, medical education, and much more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/14/2011 via PR Newswire

Kelley Habib John, acquired Seidler Bernstein Inc.

synopsis: Kelley Habib John, a Boston-based strategic brand activation firm, has announced its acquisition of Cambridge-based Seidler Bernstein, a healthcare marketing communications firm specializing in the medical device, diagnostics, and research industries.
buyer: Kelley Habib John
For more than two decades, Kelley Habib John has operated as a hybrid between a strategic consultancy and a brand communications agency, helping organizations realize their vision and drive business success by using proven methodologies to strategically activate their brands. "
target: Seidler Bernstein Inc.
Seidler Bernstein is a healthcare marketing communications firm specializing in the medical device, diagnostics, and research industries. The company uncovers customer needs and perceptions, market trends and competitive threats through a variety of resources.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/15/2010 via BusinessWire

Affiliated Computer Services, Inc., acquired TMS Health

synopsis: Affiliated Computer Services, Inc. (ACS), A Xerox Company, became one of the largest providers of customer care services to the pharmaceutical, biotech and healthcare industries with the acquisition of TMS Health from private equity firm Palm Beach Capital.
buyer parent: Xerox Corporation
buyer: Affiliated Computer Services, Inc.
Affiliated Computer Services, Inc., a global FORTUNE 500 company with 74,000 people supporting client operations reaching 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. "
target parent: Palm Beach Capital Partners
target: TMS Health
TMS Health is client-driven, passionate, nimble and responsive. TMS was founded to create and deliver professional communication programs for one of the most competitive and sophisticated market environments – healthcare and pharmaceuticals.
price ($mm)
$48
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2008 via PR Newswire

Meredith Corporation, acquired Big Communications, Inc.

synopsis: Meredith Corporation, one of America's leading media and marketing companies, announced it has acquired Big Communications, a leading healthcare marketing communications firm.
buyer: Meredith Corporation (NYSE:MDP:$3,139.30)
Meredith is one of the nation's leading media and marketing companies with businesses centering on magazine and book publishing, television broadcasting, integrated marketing and interactive media. "
target: Big Communications, Inc.
Big Communications develops custom healthcare communications for over 20 of the world's leading pharmaceutical, biotech and managed care companies. Its innovative marketing and communications programs are delivered via a variety of channels that include print, digital and mobile.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/3/2008 via BtoBonline.com

Gemini Healthcare, LLC, acquired MCM Group

synopsis: Marketing agency Gemini Healthcare has acquired MCM Group, a data analytics and benchmarking applications provider. Financial terms of the deal were not disclosed. MCM Group delivers its benchmarks programs through a proprietary platform called Total Resource Utilization that will now be available to Gemini's clients.
buyer: Gemini Healthcare, LLC
Gemini Healthcare, LLC is a healthcare marketing company based in Westbrook, Connecticut. "
target: MCM Group
The MCM Group is a healthcare communications organization. We deliver comprehensive marketing, communications and consulting solutions for pharmaceutical and biotech companies. What's uncommon about us? Superior insight.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/4/2007 via PR Newswire

CMPMedica, acquired MediReach Healthcare Communication

synopsis: United Business Media plc announces that its healthcare division CMPMedica has acquired MediReach Healthcare Communication for an initial cash consideration of $1.1 million, with a further deferred consideration of up to $2.75M contingent on future performance.
buyer parent: United Business Media PLC
buyer: CMPMedica
CMPMedica specialises in healthcare education and information for both professionals and consumers. We produce and distribute a wide range of healthcare information including medical information systems, journals, customised communications and consumer healthcare media in print, CD and net formats. "
target: MediReach Healthcare Communication
MediReach Healthcare Communication is headquartered in Shanghai and provides medical and pharmaceutical marketing consultancy services to multinational pharmaceutical companies across China. This is one of the fastest growing sectors of the Chinese healthcare market.
price ($mm)
$1.10
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/22/2011 via PR Newswire

Ignite Health, acquired Syndicated Methods, Inc

synopsis: Ignite Health, a new breed of healthcare agency combining best-in-class branding with first-in-class digital innovation, announced the acquisition of Syndicated Methods, a San Diego-based mobile development firm. The acquisition rapidly expands Ignite Health's digital leadership into the exploding mobile health space.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Ignite Health
Ignite Health is a new breed of advertising agency with a fresh approach to healthcare marketing and communications. By complementing highly focused print strategies with a wide range of tailored electronic strategies the company helps clients meet their objectives effectively and efficiently. "
target: Syndicated Methods, Inc
Syndicated Methods provides its customers with highly scalable mobile and web based software solutions, application integration, and full lifecycle development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/1/2007 via

inVentiv Health, Inc., acquired Ignite Health

synopsis: inVentiv Health, Inc. has signed a definitive agreement to acquire Ignite Health, an independent healthcare advertising agency that uses a technology-centric approach to communicate with people living with chronic diseases and those who care for them.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Ignite Health
Ignite Health is a new breed of advertising agency with a fresh approach to healthcare marketing and communications. By complementing highly focused print strategies with a wide range of tailored electronic strategies the company helps clients meet their objectives effectively and efficiently.
price ($mm)
$20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/10/2017 via BNC Analysis

inVentiv Health, Inc. will be merged with INC Research, Inc.,

synopsis: INC Research Holdings, Inc., a leading global Phase I-IV Contract Research Organization ("CRO"), and inVentiv Health, Inc., a leading, global CRO and Contract Commercial Organization will merge. INC Research shareholders will own approximately 53 percent and inVentiv shareholders will own approximately 47 percent of the merged entity.
buyer: INC Research, Inc. (SYNH:$3,472.40)
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. "
target parent: Thomas H. Lee Partners, L.P.
target: inVentiv Health, Inc.
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Their Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services.
price ($mm)[EV]
$2,453 [$4,552]
rev ($mm)
$2,156
EBITDA ($mm)
$306
EV / rev
2.1x
EV / EBITDA
14.9x
closed 10/31/2013 via PR Newswire

Adheris, Inc., purchased Catalina Health from Catalina Marketing Corporation

synopsis: inVentiv Health, offering best-in-class clinical, commercial and consulting services, announced that it has acquired Catalina Health, and combined the organization with Adheris, an inVentiv Health company. Both Adheris and Catalina Health work through pharmacies across the country to deliver adherence communications to millions of people.
buyer parent: inVentiv Health, Inc.
buyer: Adheris, Inc.
Adheris, Inc. is the leading provider of patient adherence programs in the U.S. Through its expansive retail pharmacy network of over 20,000 stores and proprietary technology, Adheris has developed a strong market position in the battle against patient pharmaceutical non-compliance. "
seller parent: Hellman & Friedman LLC
seller: Catalina Marketing Corporation
Catalina Health Resource, LLC operates a personalized health media network in the United States. It delivers patient-driven educational support and information designed to empower patients to make better health care decisions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2013 via BusinessWire

J. Knipper and Company, acquired MySTRO

synopsis: J. Knipper and Company, Inc. announced that it has acquired the inVentiv Health MySTRO Sample Management and Fulfillment business, including regulatory compliance, sample accountability, and fulfillment services. With this acquisition, the company becomes the largest end-to-end pharmaceutical samples management service provider in the U.S.
buyer: J. Knipper and Company
J. Knipper and Company, Inc., provides healthcare marketing solutions in direct marketing, sampling, compliance, information technology, and salesforce productivity. J. Knipper continues to offer innovative solutions to salesforce challenges, including MyPharmaRep.com and MySampleCloset.com. "
target parent: Thomas H. Lee Partners, L.P.
target: MySTRO
MySTRO is a leading provider of multi-channel marketing and sales force support solutions to clients in the pharmaceutical, healthcare and life-science industries. The company also offers complete outsourced sample accountability, regulatory and PDMA compliance services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2012 via PR Newswire

inVentiv Health, Inc., acquired Kazaam Interactive

synopsis: inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced that it has acquired Kazaam Interactive, a full-service interactive agency providing comprehensive solutions and services for healthcare agencies and brands.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. "
target: Kazaam Interactive
Kazaam is a full-service digital marketing agency offering premier digital strategy and solutions to brands and organizations. The company has worked with over sixty of the world's largest brands and brings a real-world understanding for utilizing the online channels.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2012 via PR Newswire

inVentiv Health, Inc., acquired Kforce Clinical Research, Inc.

synopsis: inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, announced that it has completed the acquisition of Kforce Clinical Research, Inc., a provider of functional outsourcing solutions to pharmaceutical, biotech and medical device companies, from Kforce Inc. for $50 million in cash.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. "
target parent: Kforce Inc.
target: Kforce Clinical Research, Inc.
Kforce Clinical Research Inc. provides clinical trial resourcing solutions. The company offers outsourcing and contract staffing and permanent placement services. Kforce Clinical Research Inc. operates as a subsidiary of Kforce Inc.
price ($mm)
$50
rev ($mm)
$106
EBITDA ($mm)
EV / rev
0.5x
EV / EBITDA
closed 9/8/2010 via GlobeNewswire

inVentiv Health, Inc., acquired Star Terre Santé

synopsis: inVentiv Health, a provider of end-to-end clinical development, launch and commercialization services to the healthcare industry, announced that it has acquired Substrat'Homme SA, commonly known as Star Terre Santé. Star Terre Santé will provide advertising and promotional services to inVentiv Communications' clients in France and Benelux.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is a leading, global provider of data-driven, outsourced solutions to the pharmaceutical, life sciences and healthcare industries. inVentiv's full suite of marketing, sales, clinical development and post-approval solutions drive speed and effectiveness. "
target: Star Terre Santé
Substrat'Homme SA, commonly known as Star Terre Santé, is a leading group of healthcare marketing and communications agencies based in Paris.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/4/2010 via GlobeNewswire

Thomas H. Lee Partners, L.P., acquired inVentiv Health, Inc.

synopsis: inVentiv Health, Inc., a leading provider of end-to-end clinical development, launch and commercialization services to the global pharmaceutical and healthcare industries, announced the completion of the acquisition of inVentiv Health, Inc. by Thomas H. Lee Partners, L.P.
buyer: Thomas H. Lee Partners, L.P.
Thomas H. Lee Partners, L.P. is one of the largest and oldest private equity investment firms in the United States and has raised and managed almost $20 billion of capital, making investments in over 100 businesses since its founding in 1974. "
target: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions through three core business segments.
price ($mm)[EV]
$911 [$1,175]
rev ($mm)
$1,084
EBITDA ($mm)
$137
EV / rev
1.1x
EV / EBITDA
8.7x
closed 6/26/2007 via BNC Analysis

inVentiv Health, Inc., acquired Innovative Health Strategies, Inc.

synopsis: inVentiv Health, Inc. announced that it has signed a definitive agreement to acquire Innovative Health Strategies, Inc. and the related AWAC.MD business (collectively "AWAC"), a leading provider of proprietary IT-driven cost containment and medical consulting solutions to third party administrators and insurance carriers.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Innovative Health Strategies, Inc.
AWAC(R), Innovative Health Strategies' core proprietary software platform, utilizes over 60,000 unique algorithms applied to client provider claims, pharmacy data, pre-certification and related data to uncover opportunities for cost reductions.
price ($mm)
$75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2007 via PR Newswire

inVentiv Health, Inc., acquired Addison Whitney

synopsis: Addison Whitney, a full service brand identity and consulting firm that specializes in creating unique brand solutions for global pharmaceutical, biotechnology and medical companies, announces its acquisition by inVentiv Health.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Addison Whitney
Addison Whitney is a full service brand identity consultancy. Addison Whitney Healthcare strives to provide powerful brand identity solutions to global pharmaceutical, biotechnology and medical companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/1/2007 via

inVentiv Health, Inc., acquired Ignite Health

synopsis: inVentiv Health, Inc. has signed a definitive agreement to acquire Ignite Health, an independent healthcare advertising agency that uses a technology-centric approach to communicate with people living with chronic diseases and those who care for them.
buyer: inVentiv Health, Inc.
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Ignite Health
Ignite Health is a new breed of advertising agency with a fresh approach to healthcare marketing and communications. By complementing highly focused print strategies with a wide range of tailored electronic strategies the company helps clients meet their objectives effectively and efficiently.
price ($mm)
$20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2006 via PR Newswire

Inventiv Health, acquired Maxwell Group Inc.

synopsis: inVentiv Health, Inc. has completed the acquisition of The Maxwell Group, Inc. and its MedConference brand of services. MedConference, a pioneer in the field of on-line events, e-learning and web conferencing, was founded in 1989 and is a leading provider of live and on-demand virtual event services to the pharmaceutical industry.
buyer: Inventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Maxwell Group Inc.
Maxwell supports both live web events and on-demand events on most platforms in a variety of verticals. We deliver the highest quality turnkey web event services and support tools pre-event, live event and post event.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/7/2006 via PR Newswire

Inventiv Health, acquired American Speaker Education Research and Training, LLC

synopsis: inVentiv Health, Inc. has completed the acquisition of American Speakers Education Research Training LLC (ASERT), a medical education and training company, and DialogCoach LLC, a specialty training organization that employs proprietary software tools and e-learning solutions to improve sales force effectiveness.
buyer: Inventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: American Speaker Education Research and Training, LLC
ASERT LLC is a training company that specializes in the pharmaceutical, biotechnology and medical devices industries. DialogCoach LLC is a specialty training organization developed around a proprietary software, DialogCoach, and e-learning solutions to improve sales and call center effectiveness.
price ($mm)
$5.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/5/2006 via PR Newswire

Ventiv Health, acquired Synergos, Inc.

synopsis: inVentiv Health, Inc. announced the completion of its acquisitions of Synergos, Inc., a focused clinical services provider, and Jeffrey Simbrow Associates Inc., Canada's leading healthcare marketing and communications agency. Both acquisitions were announced by inVentiv on March 13.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Synergos, Inc.
Synergos, Inc. is a functional service provider specializing in clinical trials management services, particularly project management and monitoring as well as investigator and patient recruitment. Synergos also provides regulatory affairs and quality compliance services.
price ($mm)
$5.75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/5/2006 via PR Newswire

Inchord Communications, Inc., acquired Jeffrey Simbrow Associates

synopsis: inVentiv Health, Inc. announced the completion of its acquisitions of Synergos, Inc., a focused clinical services provider, and Jeffrey Simbrow Associates Inc., Canada's leading healthcare marketing and communications agency. Both acquisitions were announced by inVentiv on March 13.
buyer parent: inVentiv Health, Inc.
buyer: Inchord Communications, Inc.
Westerville, Ohio-based inChord Communications is the largest privately held healthcare marketing organization in the world serving a broad range of clients including many of the world's top pharmaceutical companies. "
target: Jeffrey Simbrow Associates
Jeffrey Simbrow Associates is the largest healthcare- focused advertising and marketing agency in Canada and is internationally recognized for its expertise in marketing management training.
price ($mm)
$8.64
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/1/2006 via PR Newswire

Ventiv Health, acquired Adheris, Inc.

synopsis: Ventiv Health, Inc. announced the completion of its acquisition of Adheris, Inc., the industry leader in the area of patient compliance and persistency programs. Ventiv announced on February 3 that it had acquired Adheris for $60 million in cash and stock, plus earn-out payments for exceeding specified financial targets.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Adheris, Inc.
Adheris, Inc. is the leading provider of patient adherence programs in the U.S. Through its expansive retail pharmacy network of over 20,000 stores and proprietary technology, Adheris has developed a strong market position in the battle against patient pharmaceutical non-compliance.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/6/2005 via PR Newswire

Ventiv Health, acquired Inchord Communications, Inc.

synopsis: Ventiv Health, Inc. announced the completion of its acquisition of inChord Communications, Inc., the world's largest independently-owned global healthcare marketing and communications company. Ventiv announced on September 7, 2005 that it would acquire inChord for $185 million in cash and stock, plus closing adjustments and earn-out payments.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: Inchord Communications, Inc.
Westerville, Ohio-based inChord Communications is the largest privately held healthcare marketing organization in the world serving a broad range of clients including many of the world's top pharmaceutical companies.
price ($mm)
$184
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/22/2004 via PR Newswire

Ventiv Health, acquired HHI Clinical Research & Statistical Services, L.L.C.

synopsis: Ventiv Health, Inc. VTIV, a leading provider of late-stage clinical, sales, marketing and compliance services to pharmaceutical and biotech organizations, today announced that it has successfully completed the acquisition of HHI Clinical & Statistical Research Services, L.L.C.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: HHI Clinical Research & Statistical Services, L.L.C.
HHI Clinical Research & Statistical Services, L.L.C. is a focused clinical service provider managing statistical analysis and data management functions for pharmaceutical and biotechnology companies. HHI's services include data support, programming, statistical analysis and report writing. HHI has
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$9,474.88)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 8/16/2017 via BusinessWire

Evotec BioSystems GmbH, acquired Aptuit, Inc.

synopsis: Evotec announced that it has successfully completed the acquisition of Aptuit, a partner research organisation for integrated outsourced drug discovery and development solutions. This acquisition adds considerable business opportunities to further accelerate Evotec's long-term strategy to be the industry partner of choice for external innovation.
buyer: Evotec BioSystems GmbH (XTRA:EVT:$226.46)
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. "
target parent: Welsh, Carson, Anderson & Stowe
target: Aptuit, Inc.
Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators.
price ($mm)
$300
rev ($mm)
$93
EBITDA ($mm)
$12
EV / rev
3.2x
EV / EBITDA
25.8x
announced 6/20/2017 via Company Press Release

Pamplona Capital Management LLP, will acquire PAREXEL International Corporation

synopsis: Pamplona Capital Management, LLP has entered into a definitive agreement to acquire all of the outstanding shares of PAREXEL International Corporation, a leading global biopharmaceutical services provider. PAREXEL provides a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
price ($mm)[EV]
$4,508 [$4,923]
rev ($mm)
$2,097
EBITDA ($mm)
$343
EV / rev
2.4x
EV / EBITDA
14.6x
announced 5/10/2017 via BNC Analysis

inVentiv Health, Inc. will be merged with INC Research, Inc.,

synopsis: INC Research Holdings, Inc., a leading global Phase I-IV Contract Research Organization ("CRO"), and inVentiv Health, Inc., a leading, global CRO and Contract Commercial Organization will merge. INC Research shareholders will own approximately 53 percent and inVentiv shareholders will own approximately 47 percent of the merged entity.
buyer: INC Research, Inc. (SYNH:$3,472.40)
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. "
target parent: Thomas H. Lee Partners, L.P.
target: inVentiv Health, Inc.
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Their Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services.
price ($mm)[EV]
$2,453 [$4,552]
rev ($mm)
$2,156
EBITDA ($mm)
$306
EV / rev
2.1x
EV / EBITDA
14.9x
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2009 via BusinessWire

PPD, Inc., acquired Excel PharmaStudies Inc.

synopsis: PPD, Inc. announced it has completed its acquisition of Excel PharmaStudies, Inc., one of the largest contract research organizations in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions it to capitalize on the tremendous growth of the outsourcing market in Asia Pacific.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Excel PharmaStudies Inc.
Excel PharmaStudies, Inc. is a full-service provider of clinical research, registration, biometrics, and training and consultation services. Excel is the leading CRO in China and operates 22 offices worldwide, with more than 300 staff members.
price ($mm)
$16
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2009 via PR Newswire

Pierrel SpA, purchased US Operations from Encorium Group Inc.

synopsis: Encorium Group, Inc., a full service multinational clinical research organization, announced that is has completed the previously announced sale of the Company's U.S. business to Pierrel Research USA, Inc., a wholly-owned subsidiary of Pierrel SpA, an international contract research organization listed on Milano's Stock Exchange.
buyer: Pierrel SpA (PIELF:$0.00)
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use. "
seller: Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
price ($mm)[EV]
$0.08 [$2.58]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/8/2009 via PR Newswire

Next Fuel, Inc., will acquire Clinical Trials of the Americas, Inc.

synopsis: Clinical Trials of America Inc. announced that it has entered into a binding letter of intent to sell shares equal to approximately 75% of its issued and outstanding shares to Next Fuel Inc., a developer of a proprietary "On Demand" Hydrogen Generation System.
buyer: Next Fuel, Inc.
Next Fuel Inc. is a developer of a proprietary "On Demand" Hydrogen Generation System that is used as fuel for Fuel Cells which produce electricity. "
target: Clinical Trials of the Americas, Inc.
Clinical Trials of the Americas, Inc. provides clinical trial investigator services in dedicated sites throughout the Americas. Initially, we intend to introduce our services in Central America.
price ($mm)
$0.29*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2009 via PR Newswire

ASG, Inc., acquired Ockham Development Group, Inc.

synopsis: ASG, Inc. a high-quality functional outsourcing and specialty staffing services group based in Cary, North Carolina - has acquired neighboring Ockham Development Group, Inc., a full-service contract research organization.
buyer: ASG, Inc.
ASG provides high-quality functional outsourcing and specialty staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. "
target: Ockham Development Group, Inc.
Ockham Development Group Inc. is a privately held contract research organization headquartered in Cary, North Carolina.
price ($mm)
rev ($mm)
$12
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 4/22/2009 via BusinessWire

PPD, Inc., acquired AbCRO, Inc.

synopsis: PPD, Inc. announced that it has completed the acquisition of AbC.R.O., Inc., a Bulgarian contract research organization. The acquisition strengthens PPD’s ability to provide a broad range of clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs services to its growing client base in the Balkans.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: AbCRO, Inc.
AbCRO provides a full range of Phase II-IV clinical services, including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs.
price ($mm)
$36
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2009 via PR Newswire

PharmaNet Development Group, Inc. merged with JLL Partners,

synopsis: JLL Partners, a leading private equity investment fund, and PharmaNet Development Group, Inc., a leading provider of clinical development services, announced the successful completion of the tender offer by JLL PharmaNet Holdings, LLC.
buyer: JLL Partners
Founded in 1988, JLL Partners is among the leading private equity investment firms in the country. Since inception, we have managed a series of private equity funds aggregating approximately $4 billion in committed capital. "
target: PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc. is a leader in outsourced clinical development that offers clinical-development solutions including early and late stage consulting services, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs.
price ($mm)[EV]
$101 [$186]
rev ($mm)
$451
EBITDA ($mm)
$26
EV / rev
0.4x
EV / EBITDA
7.1x
closed 1/27/2009 via BusinessWire

Altarum Institute, acquired KAI Research, Inc.

synopsis: Altarum Institute, a non-profit health systems research and consulting organization, has purchased Rockville, Maryland-based KAI Research, Inc. (KAI). KAI provides innovative, cost-effective and practical support to the pharmaceutical and biotech industry, academic institutions and the National Institutes of Health.
buyer: Altarum Institute
Altarum Institute is a nonprofit health systems research and consulting organization serving government and private-sector clients. "
target: KAI Research, Inc.
KAI Research provides innovative, cost-effective and practical support to the pharmaceutical and biotech industries. KAI currently supports pharmaco-vigilance activities for over 90 marketed drugs and is providing safety surveillance for dozens of ongoing clinical trials.
price ($mm)
$7.55
rev ($mm)
$10
EBITDA ($mm)
EV / rev
0.8x
EV / EBITDA
closed 3/13/2009 via BNC Analysis

Premier Research Group, acquired Pivotal Research Centers, LLC

synopsis: PHC, Inc. d/b/a Pioneer Behavioral Health, a leading provider of inpatient and outpatient behavioral health services, announced Premier Research Arizona, LLC, a unit of Premier Research Group PLC, has signed a purchase agreement to acquire the assets of PHC's Pivotal Research Centers.
buyer: Premier Research Group
Premier Research is a leading solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. "
target parent: Pioneer Behavioral Health
target: Pivotal Research Centers, LLC
Pivotal Research Centers, LLC provides clinical drug testing. It performs all phases of clinical research for Phase I to Phase IV drugs under development through two research sites. Pivotal was founded by Louis C. Kirby in 1993 and is based in Phoenix, Arizona.
price ($mm)
$3.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/30/2007 via Company Press Release

Chiltern International Inc., acquired Clinical Trial Management Services, Inc.

synopsis: Chiltern, a leading global clinical research organization (CRO), announced the acquisition of Clinical Trial Management Services, Inc. (CTMS) a Bristol, Tennessee based CRO offering high quality services throughout the United States.
buyer: Chiltern International Inc.
Chiltern is a global CRO with experience running and staffing international Phase I to Phase IV clinical trials. Chiltern’s services include: Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. "
target: Clinical Trial Management Services, Inc.
Clinical Trial Management Services, Inc. provides clinical research services such as clinical trial management and monitoring services, such as project management, investigative site management and monitoring services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/14/2009 via BusinessWire

NexMed, Inc., acquired Bio-Quant, Inc.

synopsis: NexMed, Inc., a developer of products based on the NexACT® technology, announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA.
buyer: NexMed, Inc. (NEXM:$0.00)
NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, sexual disorders and more. "
target: Bio-Quant, Inc.
Founded in 1999, Bio-Quant is the largest specialty CRO based in San Diego and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models specializing in oncology, inflammation, immunology, and metabolic diseases, including diabetes.
price ($mm)[EV]
$13 [$13]
rev ($mm)
$5
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
announced 10/28/2009 via PR Newswire

Alpha Analytical, will acquire Boston Analytical

synopsis: Alpha Analytical is announcing the completion of the acquisition of Boston Analytical, Inc. Established in 1987, Boston Analytical is a registered, cGMP compliant contract testing laboratory providing quality analytical and microbiological testing services to the pharmaceutical, biotech, device, cosmetic and nutritional product industries.
buyer: Alpha Analytical
Alpha Analytical, Inc. provides full-service environmental laboratory solutions for the most demanding industrial and commercial applications in the U.S. and abroad. Alpha Analytical is the largest environmental laboratory in New England and among the top 18 laboratories in the country. "
target: Boston Analytical
Boston Analytical is committed to providing quality Analytical and Microbiological testing services to pharmaceutical companies worldwide in support of their Product Development, Release and Stability Testing objectives.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2009 via Company Press Release

J O Hambro Capital Management Limited, acquired Celsis International

synopsis: Chicago-based Celsis International, a leading global life sciences company, announces that it has been acquired by UK-based private equity firm J O Hambro and will de-list from the London Stock Exchange (LSE) and operate as a privately held company.
buyer: J O Hambro Capital Management Limited
J O Hambro Capital Management, the London-based boutique investment firm, offers an alternative to the large traditional fund management firms that have dominated the market for many years. "
target: Celsis International
Celsis International plc is a leading international provider of innovative life science products and laboratory services to the pharmaceutical and consumer products industries through our three divisions: Rapid Detection, Analytical Services and In Vitro Technologies.
price ($mm)[EV]
$55 [$52]*
rev ($mm)
$42
EBITDA ($mm)
$12
EV / rev
1.9x
EV / EBITDA
6.3x
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/1/2009 via Reuters

INC Research, Inc., will purchase Late Stage Research Unit from MDS, Inc.

synopsis: MDS Inc has announced that it planns to narrow its contract research focus by selling its late stage operations and central laboratory divisions to Contract Research Organization INC Research, Inc.
buyer: INC Research, Inc. (SYNH:$3,472.40)
INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting Phase I- Phase IV clinical development programs of the highest integrity. "
seller: MDS, Inc. (MDZ:$231.00)
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
price ($mm)
$45
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2009 via PR Newswire

ChemRar High-Tech Center, acquired Prudentas, LLC

synopsis: ChemDiv, a global chemistry-driven contract research organization, announced that its ChemRar High Tech Center has acquired Prudentas LLC, one of the leading CRO companies conducting high quality Phase I - Phase IV studies in Eastern Europe.
buyer parent: ChemDiv, Inc.
buyer: ChemRar High-Tech Center
The ChemRar High-Tech Center is a unique pharma and biotechnology complex founded by innovative life science organizations in Russia. ChemRar's component companies are engaged in discovering, developing and commercializing novel drugs for partners in Russia and worldwide. "
target: Prudentas, LLC
Prudentas is a Russian Clinical Contract Research Organization founded by and consisting of highly qualified clinical research professionals with extensive experience of working previously together as a team.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Ignite Health


read more

Ignite Health

Multimedia Healthcare Communication S.r.l.

Concentric Pharma Advertising

Dreams Communication

Wishbone Advertising

PharmADS.com

Alloy Fitness Network

BrokersWeb.com

Star Terre Santé

Reed Weir Communications

Consultech

Access Communications, LLC

Insight Interactive Group, Inc.

VCG

Strategic EDGE Communications, Inc.

Seidler Bernstein Inc.

TMS Health

Big Communications, Inc.

MCM Group

MediReach Healthcare Communication

read more

Syndicated Methods, Inc

Ignite Health

read more

inVentiv Health, Inc.

Catalina Marketing Corporation

MySTRO

Kazaam Interactive

Kforce Clinical Research, Inc.

Star Terre Santé

inVentiv Health, Inc.

Innovative Health Strategies, Inc.

Addison Whitney

Ignite Health

Maxwell Group Inc.

American Speaker Education Research and Training, LLC

Synergos, Inc.

Jeffrey Simbrow Associates

Adheris, Inc.

Inchord Communications, Inc.

HHI Clinical Research & Statistical Services, L.L.C.

read more

Invicro, LLC

Aptuit, Inc.

PAREXEL International Corporation

inVentiv Health, Inc.

Quintiles Transnational Corp.

Excel PharmaStudies Inc.

Encorium Group Inc.

Clinical Trials of the Americas, Inc.

Ockham Development Group, Inc.

AbCRO, Inc.

PharmaNet Development Group, Inc.

KAI Research, Inc.

Pivotal Research Centers, LLC

Clinical Trial Management Services, Inc.

Bio-Quant, Inc.

Boston Analytical

Celsis International

AAIPharma Services

MDS, Inc.

Prudentas, LLC

Geography
Matching Companies
Ticker: SYNH
 
 
 
 
 
 
 
 
INC Research, Inc.
INC Research, Inc.
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
year
2018
rev ($mm)
$3,472.40
EBITDA ($mm)
$441.82
EBIT ($mm)
$157.52
Net Income ($mm)
Employees
21000
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2017
rev ($mm)
$3,467.64
EBITDA ($mm)
$637.81
EBIT ($mm)
$406.82
Net Income ($mm)
$252.97
Employees
34651
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch
Ticker: LH
 
 
 
 
 
 
 
 
LabCorp
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp processes tests on approximately 470,000 specimens each day, applying advances in medicine and science to laboratory testing.
year
2009
rev ($mm)
$4,694.70
EBITDA ($mm)
$1,142.70
EBIT ($mm)
$949.40
Net Income ($mm)
$543.30
Employees
28000
  • drill down
  • watch